Upgrade to SI Premium - Free Trial

Evoke Pharma (EVOK) Misses Q2 EPS by 62c

August 14, 2025 7:50 AM

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.62). Revenue for the quarter came in at $3.75 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

Categories

Earnings